{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:02:04Z","timestamp":1793307724617,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DC014296"],"award-info":[{"award-number":["R01DC014296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AG065450"],"award-info":[{"award-number":["K23AG065450"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AG005134"],"award-info":[{"award-number":["P50AG005134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DC016912"],"award-info":[{"award-number":["K23DC016912"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG051987"],"award-info":[{"award-number":["R21AG051987"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG062421"],"award-info":[{"award-number":["P30AG062421"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10RR021110"],"award-info":[{"award-number":["S10RR021110"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10RR023401"],"award-info":[{"award-number":["S10RR023401"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10RR023043"],"award-info":[{"award-number":["S10RR023043"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nicl.2022.103303","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T02:28:58Z","timestamp":1671848938000},"page":"103303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Deepti","family":"Putcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brickhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryn","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Salat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Touroutoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford C.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2022.103303_b0005","doi-asserted-by":"crossref","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B., & Walker, S. (2015). Fitting Linear Mixed-Effects Models Using lme4. Journal of Statistical Software, 67(1), Article 1. 10.18637\/jss.v067.i01.","DOI":"10.18637\/jss.v067.i01"},{"issue":"6","key":"10.1016\/j.nicl.2022.103303_b0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-\u03b2 associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2022.103303_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2017.01.017","article-title":"Alzheimer\u2019s disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples","volume":"53","author":"Brenowitz","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.nicl.2022.103303_b0020","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","article-title":"Consensus classification of posterior cortical atrophy","volume":"13","author":"Crutch","year":"2017","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"10.1016\/j.nicl.2022.103303_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WAD.0000000000000196","article-title":"Tau-PET binding distinguishes patients with early-stage posterior cortical atrophy from amnestic Alzheimer disease dementia","volume":"31","author":"Day","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"10.1016\/j.nicl.2022.103303_b0030","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nicl.2022.103303_b0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"issue":"6","key":"10.1016\/j.nicl.2022.103303_b0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1017\/S109285291600047X","article-title":"Approach to atypical Alzheimer\u2019s disease and case studies of the major subtypes","volume":"22","author":"Dickerson","year":"2017","journal-title":"CNS Spectr."},{"issue":"20","key":"10.1016\/j.nicl.2022.103303_b0045","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1109\/42.906426","article-title":"Automated manifold surgery: Constructing geometrically accurate and topologically correct models of the human cerebral cortex","volume":"20","author":"Fischl","year":"2001","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.nicl.2022.103303_b0055","doi-asserted-by":"crossref","unstructured":"Fleisher, A. S., Pontecorvo, M. J., Devous, M. D., Sr, Lu, M., Arora, A. K., Truocchio, S. P., Aldea, P., Flitter, M., Locascio, T., Devine, M., Siderowf, A., Beach, T. G., Montine, T. J., Serrano, G. E., Curtis, C., Perrin, A., Salloway, S., Daniel, M., Wellman, C., \u2026 for the A16 Study Investigators. (2020). Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. JAMA Neurology, 77(7), 829\u2013839. 10.1001\/jamaneurol.2020.0528.","DOI":"10.1001\/jamaneurol.2020.0528"},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"G\u00f3mez-Isla","year":"1997","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.nicl.2022.103303_b0065","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2022.103303_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","article-title":"Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data","volume":"92","author":"Greve","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2022.103303_b0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","article-title":"Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging","volume":"132","author":"Greve","year":"2016","journal-title":"Neuroimage"},{"issue":"11","key":"10.1016\/j.nicl.2022.103303_b0080","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/hbm.22103","article-title":"Improved prediction of Alzheimer\u2019s disease with longitudinal white matter\/gray matter contrast changes","volume":"34","author":"Grydeland","year":"2013","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"10.1016\/j.nicl.2022.103303_b0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2022.103303_b0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nicl.2022.103303_b0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"10.1016\/j.nicl.2022.103303_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11682-014-9291-2","article-title":"Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters","volume":"9","author":"Jefferson","year":"2015","journal-title":"Brain Imag. Behav."},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2022.103303_b0115","article-title":"Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy","volume":"awac245","author":"Katsumi","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2022.103303_b0120","article-title":"Association of regional cortical network atrophy with progression to dementia in patients with primary progressive aphasia","author":"Katsumi","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nicl.2022.103303_b0125","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.neurobiolaging.2014.04.006","article-title":"Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer\u2019s disease","volume":"35","author":"Kljajevic","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000058331","article-title":"Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer\u2019s disease","volume":"14","author":"Mendez","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"4","key":"10.1016\/j.nicl.2022.103303_b0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"10.1016\/j.nicl.2022.103303_b0140","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: Clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2022.103303_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cortex.2018.04.010","article-title":"Executive dysfunction contributes to verbal encoding and retrieval deficits in posterior cortical atrophy","volume":"106","author":"Putcha","year":"2018","journal-title":"Cortex"},{"key":"10.1016\/j.nicl.2022.103303_b0150","article-title":"Visual cognition in non-amnestic Alzheimer\u2019s disease: relations to tau, amyloid, and cortical atrophy","volume":"23","author":"Putcha","year":"2019","journal-title":"NeuroImage: Clinical"},{"issue":"2","key":"10.1016\/j.nicl.2022.103303_b0155","doi-asserted-by":"crossref","first-page":"fcac055","DOI":"10.1093\/braincomms\/fcac055","article-title":"Tau and the fractionated default mode network in atypical Alzheimer\u2019s disease","volume":"4","author":"Putcha","year":"2022","journal-title":"Brain Commun."},{"issue":"2","key":"10.1016\/j.nicl.2022.103303_b0160","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awp326","article-title":"Increased metabolic vulnerability in early-onset Alzheimer\u2019s disease is not related to amyloid burden","volume":"133","author":"Rabinovici","year":"2010","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.nicl.2022.103303_b0165","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.0b013e31823b9c5e","article-title":"Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD","volume":"77","author":"Rabinovici","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroimage.2009.06.074","article-title":"Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast","volume":"48","author":"Salat","year":"2009","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nicl.2022.103303_b0175","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neuroimage.2010.10.034","article-title":"Hippocampal degeneration is associated with temporal and limbic gray matter\/white matter tissue contrast in Alzheimer\u2019s disease","volume":"54","author":"Salat","year":"2011","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.nicl.2022.103303_b0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.0b013e3181ea15e8","article-title":"Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia","volume":"75","author":"Sapolsky","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nicl.2022.103303_b0185","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/cercor\/bhx179","article-title":"Local-global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI","volume":"28","author":"Schaefer","year":"2018","journal-title":"Cereb. Cortex"},{"issue":"14","key":"10.1016\/j.nicl.2022.103303_b0190","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jlcr.3098","article-title":"A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807","volume":"56","author":"Shoup","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.nicl.2022.103303_b0195","article-title":"Longitudinal tau-PET uptake and atrophy in atypical Alzheimer\u2019s disease","volume":"23","author":"Sintini","year":"2019","journal-title":"NeuroImage: Clinical"},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0200","first-page":"e12133","article-title":"Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir","volume":"12","author":"Sonni","year":"2020","journal-title":"Alzheimer\u2019s Dementia: Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.nicl.2022.103303_b0205","article-title":"Measures of cortical microstructure are linked to amyloid pathology in Alzheimer\u2019s disease","volume":"awac343","author":"Spotorno","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2022.103303_b0210","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000140289.18472.15","article-title":"Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy","author":"Tang-Wai","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0215","doi-asserted-by":"crossref","first-page":"fcaa068","DOI":"10.1093\/braincomms\/fcaa068","article-title":"Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a description of 55 cases and comparison to other phenotypes","volume":"2","author":"Townley","year":"2020","journal-title":"Brain Commun."},{"issue":"7","key":"10.1016\/j.nicl.2022.103303_b0220","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nicl.2022.103303_b0225","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.neuroimage.2009.05.084","article-title":"Increased sensitivity to effects of normal aging and Alzheimer\u2019s disease on cortical thickness by adjustment for local variability in gray\/white contrast: a multi-sample MRI study","volume":"47","author":"Westlye","year":"2009","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.nicl.2022.103303_b0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuroimage.2010.03.056","article-title":"Differentiating maturational and aging-related changes of the cerebral cortex by use of thickness and signal intensity","volume":"52","author":"Westlye","year":"2010","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.nicl.2022.103303_b0235","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jalz.2018.02.020","article-title":"Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer\u2019s disease","volume":"14","author":"Whitwell","year":"2018","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"13","key":"10.1016\/j.nicl.2022.103303_b0240","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1523\/JNEUROSCI.4409-12.2013","article-title":"Alzheimer\u2019s Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not \u03b2-Amyloid in Cognitively Normal Older Individuals","volume":"33","author":"Wirth","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nicl.2022.103303_b0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/nmt-2018-0052","article-title":"Diagnostic evaluation and monitoring of patients with posterior cortical atrophy","volume":"9","author":"Wong","year":"2019","journal-title":"Neurodegen. Disease Manage."},{"issue":"4","key":"10.1016\/j.nicl.2022.103303_b0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2016.5755","article-title":"Association of In Vivo [18F]AV-1451 Tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease","volume":"74","author":"Xia","year":"2017","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.nicl.2022.103303_b0255","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/jn.00338.2011","article-title":"The organization of the human cerebral cortex estimated by intrinsic functional connectivity","volume":"106","author":"Yeo","year":"2011","journal-title":"J. Neurophysiol."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158222003680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158222003680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:38:38Z","timestamp":1781105918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158222003680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":51,"alternative-id":["S2213158222003680"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2022.103303","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2022.103303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103303"}}